Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemia

被引：53

作者：

Bassan, R. ^{[1
,2
]}

Spinelli, O. ^{[2
]}

Oldani, E. ^{[2
]}

Intermesoli, T. ^{[2
]}

Tosi, M. ^{[2
]}

Peruta, B. ^{[2
]}

Borlenghi, E. ^{[3
]}

Pogliani, E. M. ^{[4
]}

Di Bona, E. ^{[5
]}

Cassibba, V. ^{[6
]}

Scattolin, A. M. ^{[1
]}

Romani, C. ^{[7
]}

Ciceri, F. ^{[8
]}

Cortelezzi, A. ^{[9
]}

Gianfaldoni, G. ^{[10
]}

Mattei, D. ^{[11
]}

Audisio, E. ^{[12
]}

Rambaldi, A. ^{[2
]}

机构：

[1] Osped Angelo, UOC Ematol, Mestre Venezia, Italy

[2] Osped Papa Giovanni XXIII, USC Ematol, Bergamo, Italy

[3] Spedali Civil Brescia, Div Ematol, I-25125 Brescia, Italy

[4] Osped San Gerardo, Clin Ematol, Monza, Italy

[5] Osped S Bortolo, UOC Ematol, Vicenza, Italy

[6] Osped Civile, Div Ematol, Bolzano, Italy

[7] Osped Oncol Riferimento Reg, UO Ematol, Cagliari, Italy

[8] Ist Scient HS Raffaele, UO Ematol, Milan, Italy

[9] Univ Milan, IRCCS Ca Granda Osped Maggiore Policlin, UO Ematol, Milan, Italy

[10] Univ Florence, Florence, Italy

[11] ASO S Croce & Carle, SC Ematol, Cuneo, Italy

[12] Univ Turin, Osped San Giovanni Battista, Turin, Italy

来源：

BLOOD CANCER JOURNAL | 2014年 / 4卷

关键词：

MRD;

D O I：

10.1038/bcj.2014.48

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：e225 / e225

页数：4

共 15 条

[1] Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL) [J].

Bassan, Renato ;

Spinelli, Orietta ;

Oldani, Elena ;

Intermesoli, Tamara ;

Tosi, Manuela ;

Peruta, Barbara ;

Rossi, Giuseppe ;

Borlenghi, Erika ;

Pogliani, Enrico M. ;

Terruzzi, Elisabetta ;

Fabris, Pietro ;

Cassibba, Vincenzo ;

Lambertenghi-Deliliers, Giorgio ;

Cortelezzi, Agostino ;

Bosi, Alberto ;

Gianfaldoni, Giacomo ;

Ciceri, Fabio ;

Bernardi, Massimo ;

Gallamini, Andrea ;

Mattei, Daniele ;

Di Bona, Eros ;

Romani, Claudio ;

Scattolin, Anna Maria ;

Barbui, Tiziano ;

Rambaldi, Alessandro .

BLOOD, 2009, 113 (18) :4153-4162

[2] CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia [J].

Brentjens, Renier J. ;

Davila, Marco L. ;

Riviere, Isabelle ;

Park, Jae ;

Wang, Xiuyan ;

Cowell, Lindsay G. ;

Bartido, Shirley ;

Stefanski, Jolanta ;

Taylor, Clare ;

Olszewska, Malgorzata ;

Borquez-Ojeda, Oriana ;

Qu, Jinrong ;

Wasielewska, Teresa ;

He, Qing ;

Bernal, Yvette ;

Rijo, Ivelise V. ;

Hedvat, Cyrus ;

Kobos, Rachel ;

Curran, Kevin ;

Steinherz, Peter ;

Jurcic, Joseph ;

Rosenblat, Todd ;

Maslak, Peter ;

Frattini, Mark ;

Sadelain, Michel .

SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (177)

[3] Has MRD monitoring superseded other prognostic factors in adult ALL? [J].

Brueggemann, Monika ;

Raff, Thorsten ;

Kneba, Michael .

BLOOD, 2012, 120 (23) :4470-4481

[4] Prognostic and therapeutic implications of minimal residual disease at the time of transplantation in acute leukemia [J].

Buckley, S. A. ;

Appelbaum, F. R. ;

Walter, R. B. .

BONE MARROW TRANSPLANTATION, 2013, 48 (05) :630-641

[5] Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adults With Philadelphia Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL): Results From The Group For Research On Adult ALL (GRAALL) [J].

Dhedin, Nathalie ;

Anne Huynh ;

Maury, Sebastien ;

Tabrizi, Reza ;

Thomas, Xavier ;

Chevallier, Patrice ;

Stephanie Nguyen ;

Coiteux, Valerie ;

Hunault, Mathilde ;

de Botton, Stephane ;

Hichri, Yosr ;

Escoffre-Barbe, Martine ;

Reman, Oumedaly ;

Chalandon, Yves ;

Blaise, Didier ;

Raus, Nicole ;

Lheritier, Veronique ;

Cahn, Jean-Yves ;

Dombret, Herve ;

Ifrah, Norbert .

BLOOD, 2013, 122 (21)

[6] Donor lymphocyte infusions for the treatment of minimal residual disease in acute leukemia [J].

Dominietto, Alida ;

Pozzi, Sarah ;

Miglino, Maurizio ;

Albarracin, Flavio ;

Piaggio, Giovanna ;

Bertolotti, Francesca ;

Grasso, Raffaella ;

Zupo, Simona ;

Raiola, Anna Maria ;

Gobbi, Marco ;

Frassoni, Francesco ;

Bacigalupo, Andrea .

BLOOD, 2007, 109 (11) :5063-5064

[7] Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies [J].

Goekbuget, Nicola ;

Kneba, Michael ;

Raff, Thorsten ;

Trautmann, Heiko ;

Bartram, Claus-Rainer ;

Arnold, Renate ;

Fietkau, Rainer ;

Freund, Mathias ;

Ganser, Arnold ;

Ludwig, Wolf-Dieter ;

Maschmeyer, Georg ;

Rieder, Harald ;

Schwartz, Stefan ;

Serve, Hubert ;

Thiel, Eckhard ;

Brueggemann, Monika ;

Hoelzer, Dieter .

BLOOD, 2012, 120 (09) :1868-1876

[8] High single-drug activity of nelarabine in relapsed T-lymphoblastic leukemia/lymphoma offers curative option with subsequent stem cell transplantation [J].

Goekbuget, Nicola ;

Basara, Nadezda ;

Baurmann, Herrad ;

Beck, Joachim ;

Brueggemann, Monika ;

Diedrich, Helmut ;

Gueldenzoph, Bjoern ;

Hartung, Gernot ;

Horst, Heinz-August ;

Huettmann, Andreas ;

Kobbe, Guido ;

Naumann, Ralph ;

Ratei, Richard ;

Reichle, Albrecht ;

Serve, Hubert ;

Stelljes, Matthias ;

Viardot, Andreas ;

Wattad, Mohammed ;

Hoelzer, Dieter .

BLOOD, 2011, 118 (13) :3504-3511

[9] In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993) [J].

Goldstone, Anthony H. ;

Richards, Susan M. ;

Lazarus, Hillard M. ;

Tallman, Martin S. ;

Buck, Georgina ;

Fielding, Adele K. ;

Burnett, Alan K. ;

Chopra, Raj ;

Wiernik, Peter H. ;

Foroni, Letizia ;

Paietta, Elisabeth ;

Litzow, Mark R. ;

Marks, David I. ;

Durrant, Jill ;

McMillan, Andrew ;

Franklin, Ian M. ;

Luger, Selina ;

Ciobanu, Niculae ;

Rowe, Jacob M. .

BLOOD, 2008, 111 (04) :1827-1833

[10] Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia [J].

Kantarjian, Hagop ;

Thomas, Deborah ;

Jorgensen, Jeffrey ;

Kebriaei, Partow ;

Jabbour, Elias ;

Rytting, Michael ;

York, Sergernne ;

Ravandi, Farhad ;

Garris, Rebecca ;

Kwari, Monica ;

Faderl, Stefan ;

Cortes, Jorge ;

Champlin, Richard ;

O'Brien, Susan .

CANCER, 2013, 119 (15) :2728-2736

← 1 2 →